SE0001499L - Medel för att förbättra cerebral frisättning av acetylkolin - Google Patents
Medel för att förbättra cerebral frisättning av acetylkolinInfo
- Publication number
- SE0001499L SE0001499L SE0001499A SE0001499A SE0001499L SE 0001499 L SE0001499 L SE 0001499L SE 0001499 A SE0001499 A SE 0001499A SE 0001499 A SE0001499 A SE 0001499A SE 0001499 L SE0001499 L SE 0001499L
- Authority
- SE
- Sweden
- Prior art keywords
- anisoyl
- release
- gaba
- acetylcholine
- anisic acid
- Prior art date
Links
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004373 acetylcholine Drugs 0.000 title abstract 3
- 230000002490 cerebral effect Effects 0.000 title 1
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 abstract 5
- DZTVZKSCFQIBMV-UHFFFAOYSA-N 4-[(4-methoxybenzoyl)amino]butanoic acid Chemical compound COC1=CC=C(C(=O)NCCCC(O)=O)C=C1 DZTVZKSCFQIBMV-UHFFFAOYSA-N 0.000 abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000017164 Chronobiology disease Diseases 0.000 abstract 1
- 230000006399 behavior Effects 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99108223 | 1999-04-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE0001499D0 SE0001499D0 (sv) | 2000-04-26 |
| SE0001499L true SE0001499L (sv) | 2000-10-28 |
Family
ID=8238054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0001499A SE0001499L (sv) | 1999-04-27 | 2000-04-26 | Medel för att förbättra cerebral frisättning av acetylkolin |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20030073744A1 (sv) |
| JP (1) | JP2000309529A (sv) |
| KR (1) | KR100372906B1 (sv) |
| CN (1) | CN1277019A (sv) |
| AR (1) | AR023763A1 (sv) |
| AT (1) | AT408836B (sv) |
| AU (1) | AU3011300A (sv) |
| BE (1) | BE1013314A3 (sv) |
| BR (1) | BR0002381A (sv) |
| CA (1) | CA2307022A1 (sv) |
| DE (1) | DE10020237A1 (sv) |
| DK (1) | DK200000687A (sv) |
| ES (1) | ES2176078A1 (sv) |
| FI (1) | FI20000977A (sv) |
| FR (1) | FR2792833B1 (sv) |
| GB (1) | GB2351662A (sv) |
| GR (1) | GR1003591B (sv) |
| IE (1) | IE20000308A1 (sv) |
| IT (1) | IT1318490B1 (sv) |
| NL (1) | NL1015043C2 (sv) |
| PT (1) | PT102456B (sv) |
| SE (1) | SE0001499L (sv) |
| TR (1) | TR200001133A2 (sv) |
| ZA (1) | ZA200002041B (sv) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5273731B2 (ja) * | 2009-08-11 | 2013-08-28 | 独立行政法人産業技術総合研究所 | 生体リズムの制御剤 |
| CA3119517C (en) * | 2018-11-13 | 2023-08-22 | Xianfeng PENG | Use of acylated derivative of amino acid in preparing animal feed additive |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU21107A3 (es) * | 1978-02-10 | 1988-02-01 | Hoffmann La Roche | Pyrrolidines derivatives |
| JPH1081626A (ja) * | 1996-09-06 | 1998-03-31 | Kamiyama:Kk | チロシナーゼ活性阻害剤 |
| JPH1081607A (ja) * | 1996-09-06 | 1998-03-31 | Kamiyama:Kk | 抗菌剤 |
-
2000
- 2000-04-21 IT IT2000MI000914A patent/IT1318490B1/it active
- 2000-04-21 FR FR0005180A patent/FR2792833B1/fr not_active Expired - Fee Related
- 2000-04-24 GR GR20000100145A patent/GR1003591B/el unknown
- 2000-04-24 JP JP2000121904A patent/JP2000309529A/ja active Pending
- 2000-04-24 KR KR10-2000-0021630A patent/KR100372906B1/ko not_active IP Right Cessation
- 2000-04-25 AR ARP000101934A patent/AR023763A1/es not_active Application Discontinuation
- 2000-04-25 ZA ZA200002041A patent/ZA200002041B/xx unknown
- 2000-04-25 AT AT0071600A patent/AT408836B/de not_active IP Right Cessation
- 2000-04-25 DE DE10020237A patent/DE10020237A1/de not_active Withdrawn
- 2000-04-25 IE IE20000308A patent/IE20000308A1/en not_active IP Right Cessation
- 2000-04-25 DK DK200000687A patent/DK200000687A/da not_active Application Discontinuation
- 2000-04-25 GB GB0010049A patent/GB2351662A/en not_active Withdrawn
- 2000-04-26 AU AU30113/00A patent/AU3011300A/en not_active Abandoned
- 2000-04-26 SE SE0001499A patent/SE0001499L/sv unknown
- 2000-04-26 PT PT102456A patent/PT102456B/pt not_active IP Right Cessation
- 2000-04-26 FI FI20000977A patent/FI20000977A/sv not_active IP Right Cessation
- 2000-04-26 BE BE2000/0294A patent/BE1013314A3/fr not_active IP Right Cessation
- 2000-04-26 ES ES200001063A patent/ES2176078A1/es active Pending
- 2000-04-26 TR TR2000/01133A patent/TR200001133A2/xx unknown
- 2000-04-26 BR BR0002381-7A patent/BR0002381A/pt not_active IP Right Cessation
- 2000-04-26 CA CA002307022A patent/CA2307022A1/en not_active Abandoned
- 2000-04-27 CN CN00118155A patent/CN1277019A/zh active Pending
- 2000-04-27 NL NL1015043A patent/NL1015043C2/nl not_active IP Right Cessation
-
2002
- 2002-12-04 US US10/309,434 patent/US20030073744A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59712501D1 (de) | 1-benzyl-3-(substituiertes-hetaryl)-kondensierten pyrazol-derivaten zur behandlung von erkrankungen des herz-kreislaufsystems und des zentralnervensystems | |
| NO20100496L (no) | Derivater av venlafaksin og anvendelse av samme | |
| NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
| DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| DE60321929D1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| BR0309875A (pt) | métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto | |
| WO2007100366A3 (en) | Quinolone m1 receptor positive allosteric modulators | |
| ATE73331T1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| EA200701296A1 (ru) | 3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства | |
| HK1118282A1 (en) | Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase | |
| ATE411280T1 (de) | Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege | |
| PE20090363A1 (es) | Moduladores de la gamma secretasa | |
| DE502005008971D1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht | |
| EE200100491A (et) | Tetrahüdropüraani derivaadid, nende saamine ja kasutamine ravimainetena ning neid sisaldav farmatseutiline kompositsioon | |
| ATE367387T1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| AU2284001A (en) | Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone | |
| ATE422201T1 (de) | 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen | |
| MXPA05013226A (es) | Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas. | |
| ATE422892T1 (de) | Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle | |
| UY26426A1 (es) | Nuevos compuestos | |
| WO2005123651A8 (en) | L-2-(α-HYDROXYPENTYL)BENZOATES, THE PREPARATION AND THE USE THEREOF | |
| WO2002005801A3 (en) | Compositions containing diacyltartaric salts of (e)-metanicotine | |
| SE0001499L (sv) | Medel för att förbättra cerebral frisättning av acetylkolin | |
| ATE136896T1 (de) | Piperidylmethyl substituierte chromanderivate als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems | |
| WO2002042256A3 (en) | N-alkylated gaba compounds, processes for their preparation and their use as medicaments |